- Home
- NVST vs SRRK Comparison
NVST vs SRRK Comparison
Compare NVST & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- SRRK
- Stock Information
- Founded
- NVST 2018
- SRRK 2012
- Country
- NVST United States
- SRRK United States
- Employees
- NVST N/A
- SRRK N/A
- Industry
- NVST Medical/Dental Instruments
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVST Health Care
- SRRK Health Care
- Exchange
- NVST Nasdaq
- SRRK Nasdaq
- Market Cap
- NVST 3.4B
- SRRK 3.0B
- IPO Year
- NVST 2019
- SRRK 2018
- Fundamental
- Price
- NVST $19.98
- SRRK $29.27
- Analyst Decision
- NVST Buy
- SRRK Strong Buy
- Analyst Count
- NVST 12
- SRRK 9
- Target Price
- NVST $20.91
- SRRK $47.88
- AVG Volume (30 Days)
- NVST 1.8M
- SRRK 3.2M
- Earning Date
- NVST 10-30-2025
- SRRK 11-14-2025
- Dividend Yield
- NVST N/A
- SRRK N/A
- EPS Growth
- NVST N/A
- SRRK N/A
- EPS
- NVST 0.31
- SRRK N/A
- Revenue
- NVST $2,552,900,000.00
- SRRK N/A
- Revenue This Year
- NVST $6.47
- SRRK N/A
- Revenue Next Year
- NVST $3.25
- SRRK $1,911.27
- P/E Ratio
- NVST $64.06
- SRRK N/A
- Revenue Growth
- NVST 0.76
- SRRK N/A
- 52 Week Low
- NVST $14.22
- SRRK $22.71
- 52 Week High
- NVST $23.00
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- NVST 46.37
- SRRK 40.43
- Support Level
- NVST $19.71
- SRRK $29.00
- Resistance Level
- NVST $20.64
- SRRK $31.85
- Average True Range (ATR)
- NVST 0.50
- SRRK 2.03
- MACD
- NVST 0.05
- SRRK -0.34
- Stochastic Oscillator
- NVST 64.71
- SRRK 12.02
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.